Drug Name:
ADVIL COLD & SINUS OTC
Generic Name and Formulations:
Ibuprofen 200mg, pseudoephedrine HCl 30mg; coated-caplets; liqui-gels.
Company:
Pfizer Consumer Healthcare
Therapeutic Use:
Indications for ADVIL COLD & SINUS:
Nasal congestion, sinus pressure, headache, minor aches and pains, fever.
Adult:
Take with food. 1–2 caplets every 4–6hrs; max 6 caplets/24hrs.
Children:
<12yrs: not recommended.
Contraindications:
Aspirin allergy. Immediately before or after cardiac surgery. During or within 14 days of MAOIs.
Warnings/Precautions:
Increased risk of severe stomach bleeding (esp. ≥60yrs old). History of GI disorders (eg, heartburn, bleeding ulcers). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Thyroid disease. Diabetes. GI or urinary obstruction. Reevaluate if fever persists or worsens >3 days or nasal congestion lasts >7 days. Elderly. Pregnancy (avoid during 3rd trimester). Nursing mothers.
Pharmacological Class:
NSAID + sympathomimetic.
Interactions:
Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Caution with diuretics. Avoid aspirin, pseudoephedrine-containing products, other pain relievers or nasal decongestants. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAIDs, ≥3 alcoholic drinks/day, or prolonged use.
Adverse Reactions:
Nervousness, dizziness, insomnia, GI upset/bleed, symptoms of heart problems or stroke (eg, trouble breathing, feel faint, slurred speech), redness, swelling, allergic reactions; discontinue if occur.
How Supplied:
Caplets—20, 40; Liqui-Gels—32
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |